Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A New Targeted Model of Experimental Autoimmune Encephalomyelitis in the Common Marmoset.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Natalizumab therapy for multiple sclerosis.
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.
(+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats.
A role for human brain pericytes in neuroinflammation.
Exercise therapy for fatigue in multiple sclerosis.
Subacute CNS demyelination after treatment with nivolumab for melanoma.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Multiple sclerosis in men: management considerations.
During Infection Theiler's Virions are Cleaved by Caspases and Disassembled into Pentamers.
Immune reconstitution inflammatory syndrome and natalizumab-Is it possible before removing the drug?
Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight.
IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.
Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Organic Causes of Erectile Dysfunction in Men Under 40.
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
Erratum to: Altered serotonin transporter availability in patients with multiple sclerosis.
Dermatoglyphic features in patients with multiple sclerosis.
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.

Pages